Ashok Leyland skids 2% on profit-booking, subsidiary secures $50-mn funding
The capital infusion will empower the company to bolster its research and development capabilities, leveraging organic growth and strategic acquisitions.
Symbol | Last Price | Change | % Change |
---|---|---|---|